MyJournals Home  

RSS FeedsCost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China (BMC Cancer)

 
 

14 october 2020 01:57:42

 
Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China (BMC Cancer)
 


In this study, we analyze the cost-effectiveness of fruquintinib as third-line treatment for patients with metastatic colorectal cancer in China, especially after a recent price drop suggested by the National ...


 
293 viewsCategory: Oncology
 
Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases (BMC Cancer)
The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China (Radiation Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten